Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 108-112

  Liu, Lide ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b   Williamson, Peter R ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; MELANIN;

ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CHEMICAL ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

CRYPTOCOCCUS NEOFORMANS;

EID: 0032893412     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.108-112.1999     Document Type: Article

References (45)

1. Campbell, L. L., M. V. Hobbs, P. Kemper, and M. B. A. Oldstone. 1994. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 150:716-720.
2. Carstam, R., A. Brinck, A. Hindemith-Augustsson, H. Rorsman, and E. Rosengren. 1991. The neuromelanin of the human substantia nigra. Biochim. Biophys. Acta 1097:152-160.
3. Cohen, G., and P. Werner. 1994. Free radicals, oxidative stress, and neurodegeneration, p. 195-204. In D. B. Calne (ed.), Neurodegenerative diseases. Saunders, Philadelphia, Pa.
4. Davies, K. J. 1995. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61:1-31.
5. del Marmol, V., S. Ito, I. Jackson, J. Vachtenheim, P. Berr, G. Ghanem, R. Morandini, K. Wakamatsu, and G. Huez. 1993. TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture. FEBS Lett. 327: 307-310.
6. Hadesman, R., R. H. Wiesner, V. L. W. Go, and G. M. Tyce. 1995. Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy. J. Neurochem. 65:1166-1175.
7. 3H]dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63:1126-1132.
8. Hirsch, E. C. 1994. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Mol. Neurobiol. 9:135-142.
9. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507-3516.
10. Ito, S. 1998. Advances in chemical analysis of melanins, p. 439-450. In J. J. Nordlund, R. E. Boissy, V. J. Hearing, R. A. King, and J. P. Ortonne (ed.), The pigmentary system: physiology and pathophysiology. Oxford University Press, New York, N. Y.
11. Ito, S. 1993. High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control. J. Invest. Dermatol. 100: 166S-171S.
12. Ito, S., and K. Fujita. 1985. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem. 144:527-536.
13. Ito, S., T. Kato, and K. Fujita. 1988. Covalent binding of catechols to proteins through the sulphydryl group. Biochem. Pharmacol. 37:1707-1710.
14. Ito, S., and J. A. C. Nicol. 1974. Isolation of oligomers of 5,6-dihydroxylindole-2-carboxylic acid from the eye of the catfish. Biochem. J. 143:207-217.
15. Ito, S., and K. Wakamatsu. 1998. Chemical degradation of melanins. Application to identification of dopamine-melanin. Pigm. Cell Res. 11:120-126.
16. Jacobson, E. S., and H. S. Emery. 1991. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J. Bacteriol. 173:401-403.
17. Jacobson, E. S., N. D. Jenkins, and J. M. Todd. 1994. Relationship between superoxide dismutase and melanin in a pathogenic fungus. Infect. Immun. 62:4085-4086.
18. Kwon-Chung, K. J., and J. E. Bennett. 1992. Cryptococcosis, p. 397-446. In K. J. Kwon-Chung and J. E. Bennett (ed.), Medical mycology. Lea and Febiger, Philadelphia, Pa.
19. Kwon-Chung, K. J., W. B. Hill, and J. E. Bennett. 1981. New, special stain for histopathological diagnosis of cryptococcosis. J. Clin. Microbiol. 13:383-387.
20. Lee, S. C., D. W. Dickson, and A. Casadevall. 1996. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenic implications. Hum. Pathol. 27:839-847.
21. Lim, T. S., J. W. Murphy, and L. K. Cauley. 1980. Host-etiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice. Infect. Immun. 29:633-641.
22. Montine, T. J., M. J. Picklo, V. Amarnath, W. O. Whetsell, and D. G. Graham. 1997. Neurotoxicity of endogenous cysteinylcatechols. Exp. Neurol. 148:26-33.
23. Mukherjee, S., S. Lee, J. Mukherjee, M. D. Scharf, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
24. Napolitano, A., A. Pezella, M. R. Vincensi, and G. Prota. 1995. Oxidative degradation of melanins to pyrrole acids: a model study. Tetrahedron 51: 5913-5920.
25. Napolitano, A., A. Pezzella, M. R. Vincensi, and G. Prota. 1996. New pyrrole acids by oxidative degradation of eumelanins with hydrogen peroxide. Further hints to the mechanism of pigment breakdown. Tetrahedron 52:8775-8780.
26. Nosanchuk, J. D., and A. Casadevall. 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect. Immun. 65:1836-1841.
27. Polak, A. 1990. Melanin as a virulence factor in pathogenic fungi. Mycoses 33:215-224.
28. Porebska-Budny, M., N. L. Sakina, K. B. Stepien, A. E. Dontsov, and T. Wilczok. 1992. Antioxidative activity of synthetic melanins. Cardiolipin liposome model. Biochim. Biophys. Acta 1116:11-16.
29. Prota, G. 1992. Melanins and melanogenesis. Academic Press, San Diego, Calif.
30. Riederer, P., E. Sofic, R. Wolf-Dieter, B. Schmidt, G. P. Reynolds, K. Jellinger, and M. B. H. Youdim. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:515-520.
31. Riley, P. A. 1997. Melanin. Int. J. Biochem. Cell. Biol. 29:1235-1239.
32. Salas, S. D., J. E. Bennett, K. J. Kwon-Chung, J. R. Perfect, and P. R. Williamson. 1996. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377-386.
33. Salkowski, C. A., and E. Balish. 1990. Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect. Immun. 58:3300-3306.
34. Spina, M. B., and G. Cohen. 1989. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. USA 86:1398-1400.
35. Staib, F. 1962. Cryptococcus neoformans and Guizotia abyssinica (syn. G. oleifera D.C.) (farbreadktion fur C. neoformans). Z. Hyg. 148:466-475.
36. Terland, O., T. Flatmark, A. Tangeras, and M. Gronberg. 1997. Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species. J. Mol. Cell. Cardiol. 29:1731-1738.
37. Tse, D. C. S., L. R. McCreery, and R. N. Adams. 1976. Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19:37-41.
38. Wakamatsu, K., S. Ito, and T. Nagatsu. 1991. Cysteinyldopamine is not incorporated into neuromelanin. Neurosci. Lett. 131:57-60.
39. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
40. Wang, Y., P. Aisen, and A. Casadevall. 1996. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:2420-2424.
41. Wang, Y., and A. Casadevall. 1994. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38:2648-2650.
42. Williamson, P. 1997. Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front. Biosci. 2:E99-E107. (Online.)
43. Williamson, P. R. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656-664.
44. Williamson, P. R., K. Wakamatsu, and S. Ito. 1998. Melanin biosynthesis in Cryptococcus neoformans. J. Bacteriol. 180:1570-1572.
45. Youdim, M. B., D. Ben-Shachar, and P. Riederer. 1994. The enigma of neuromelanin in Parkinson's disease substantia nigra. J. Neural Transm. Suppl. 43:113-122.